DAVID POPLACK to Leukemia, Myeloid, Acute
This is a "connection" page, showing publications DAVID POPLACK has written about Leukemia, Myeloid, Acute.
Connection Strength
0.167
-
A phase II trial of continuous-infusion 6-mercaptopurine for childhood leukemia. Cancer Chemother Pharmacol. 1992; 30(2):155-7.
Score: 0.065
-
Modulation of thiopurine cytotoxicity in the HL-60 cell line by physiological concentrations of hypoxanthine. Cancer Res. 1986 Dec; 46(12 Pt 1):6286-9.
Score: 0.046
-
Leukemic relapse 5 1/2 years after allogeneic bone marrow transplantation. Blood. 1978 Aug; 52(2):281-4.
Score: 0.026
-
Characteristics of long-term survivors in AML. Med Pediatr Oncol. 1978; 5(1):219-23.
Score: 0.025
-
Reversible dementia temporally associated with intraventricular therapy with methotrexate in a child with acute myelogenous leukemia. J Pediatr. 1976 Jan; 88(1):131-3.
Score: 0.005